
    
      The CONDI2/ERIC-PPCI trial is a randomised controlled clinical trial investigating whether
      remote ischemic conditioning (RIC) can reduce cardiac death and hospitalization for heart
      failure at 12 months in 5400 patients presenting with a ST-elevation myocardial infarction
      (STEMI) and treated by percutaneous coronary intervention (PPCI).
    
  